.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Farmers Insurance
Fish and Richardson
Cantor Fitzgerald
US Army
Colorcon
Novartis
Healthtrust
Merck

Generated: June 24, 2017

DrugPatentWatch Database Preview

ABACAVIR SULFATE AND LAMIVUDINE Drug Profile

« Back to Dashboard

Which patents cover Abacavir Sulfate And Lamivudine, and when can generic versions of Abacavir Sulfate And Lamivudine launch?

Abacavir Sulfate And Lamivudine is a drug marketed by Cipla Ltd, Teva Pharms Usa, Aurobindo Pharma Ltd, and Lupin Ltd. and is included in four NDAs.

The generic ingredient in ABACAVIR SULFATE AND LAMIVUDINE is abacavir sulfate; lamivudine. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the abacavir sulfate; lamivudine profile page.

Summary for Tradename: ABACAVIR SULFATE AND LAMIVUDINE

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list4
Clinical Trials: see list104,433
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ABACAVIR SULFATE AND LAMIVUDINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla Ltd
ABACAVIR SULFATE AND LAMIVUDINE
abacavir sulfate; lamivudine
TABLET;ORAL091144-001Mar 28, 2017ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
ABACAVIR SULFATE AND LAMIVUDINE
abacavir sulfate; lamivudine
TABLET;ORAL204990-001Mar 28, 2017ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
ABACAVIR SULFATE AND LAMIVUDINE
abacavir sulfate; lamivudine
TABLET;ORAL079246-001Sep 29, 2016ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
ABACAVIR SULFATE AND LAMIVUDINE
abacavir sulfate; lamivudine
TABLET;ORAL206151-001Mar 28, 2017ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
McKesson
Colorcon
Medtronic
Covington
Johnson and Johnson
Cipla
Accenture
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot